US FDA approves Johnson & Johnson’s drug for immune-mediated disorder | Mint
[ad_1] Health care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug to treat patients aged 12 years and older with an immune-mediated disorder. The drug was approved for patients with a form of generalized myasthenia gravis (gMG) – an immunity-related disorder that weakens the skeletal muscles,…